Answers are grounded in this paper and cite their sources.
Multicentric analysis shows no significant outcome difference in aquablation with median lobe presence, implying effective symptom relief.
Abstract INTRODUCTION AND OBJECTIVE: While the efficacy of Aquablation is established for varying prostate sizes, specific outcomes in patients with a median lobe have not been well studied. We evaluated the differences in perioperative and functional outcomes in patients undergoing Aquablation with and without a median lobe. METHODS: We performed an analysis of the International Collaborative Aquablation Research Urology Society (ICARUS) database, a multicentric international database. Patients were grouped based on the presence or absence of a median lobe. Operative characteristics (operative time, adverse events) as well as functional outcomes up to 24 months postoperatively including post-void residual (PVR) volume, International Prostate Symptom Score (IPSS), maximum urinary flow rate (Qmax), and the Sexual Health Inventory for Men (SHIM) questionnaires were assessed. RESULTS: A total of 1,999 men were included: 755 (38%) patients did not have a median lobe while 1,244 patients (62%) had a median lobe. Median (IQR) prostate volumes were 76 (54-106) mL and 80 (60-110) mL for each group, respectively (p=0.009). Baseline medications, including α-blockers and 5α-reductase inhibitors (5ARIs), were similar between groups. Total operative time (49 vs. 58 min, p<0.0001) and Aquablation time (6.3 vs. 7.3 min, p<0.0001) were slightly longer for those with a median lobe. Postoperative outcomes, including improvements in IPSS, IPSS-QoL, Qmax, and PVR were similar between groups. Rates of retrograde ejaculation were slightly higher in the median lobe cohort (11.2% vs 8.1%; p=0.0002), but there were no differences in postoperative SHIM scores. Adverse events including blood transfusions did not significantly differ between groups. CONCLUSIONS: The presence of a median lobe does not have a significant impact on the outcomes of Aquablation in a real-world setting. Using a large multicentric international database, this study demonstrates that Aquablation provides effective symptom relief and safety for both groups.
No takes yet. Share an insight, caveat, or question.
Ohana et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: